One of the ways in which pharmaceutical companies can help curb rapidly rising antimicrobial resistance (AMR) is by manufacturing responsibly, with a recently published report from the Access to Medicine Foundation setting out steps pharmaceutical companies can take to limit AMR risk in the production of their lifesaving antibiotics.
Building on examples from this report, the Access to Medicine Foundation will be hosting a live webinar, titled ‘The critical role of responsible manufacturing in addressing AMR: A path forward’. The webinar is being held in collaboration with the World Health Organization (WHO) during this year’s World AMR Awareness Week and will focus on how we can move forward in ensuring responsible manufacturing of companies to limit the risk of AMR. The webinar will shed light on the major changes that are needed to improve the landscape and includes the roles that different stakeholders have to play, including companies, regulators, procurers and investors.
About the webinar
The discussion will touch on practical examples of how companies can invest in responsible manufacturing practices to not only curb AMR, but to adapt to the changing landscape within antibiotic manufacturing. Specifically, speakers will share insights on the path forward, including expectations from the investment community and potential changes in the regulatory environment that will focus on antibiotic manufacturing.
Martijn van Gerven, Research Coordinator, Access to Medicine Foundation
Abigail Herron, Global Head of ESG and Strategic Partnerships, Aviva Investors
Kate Medlicott, Team Leader, Sanitation, WHO
Jennifer Wright, Head of Environment and Sustainability at Pfizer
Register for the webinar
To join this live event, please follow this link to register your attendance.